Aggressive Multimodality Therapy for a Urachal Rhabdomyosarcoma
N Valeska Halstead1, Nina Mikkilineni1, Carrye R Cost2
1University of Colorado Anschutz Medical Campus, Children's Hospital of Colorado, Division of Pediatric Urology, Aurora, CO.
This case report details a rare urachal rhabdomyosarcoma in a 2-year-old boy. Successful treatment involved surgery and chemoradiation, leading to a positive outcome.
Area of Science:
- Pediatric Oncology
- Urologic Oncology
Background:
- Urachal rhabdomyosarcoma is a rare pediatric malignancy with a historically poor prognosis.
- Early detection and multimodal treatment are crucial for improving outcomes.
Observation:
- A 2-year-old male presented with abdominal pain, fatigue, and urinary frequency.
- Imaging and pathological examination confirmed primary embryonal rhabdomyosarcoma of the urachus.
Findings:
- The patient underwent upfront surgical resection followed by adjuvant chemoradiation.
- Treatment followed the Children's Oncology Group protocol D9803.
Implications:
- This case highlights a successful treatment approach for a rare and aggressive pediatric cancer.
- Multimodal therapy, including surgery and chemoradiation, can lead to favorable outcomes in urachal rhabdomyosarcoma.
More Related Videos
07:50Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
Published on: May 25, 2018
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Related Concept Videos
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
